Platelet decline as a predictor of brain injury in HIV infection

Journal of NeuroVirology

Volumn 17, Issue 5, 2011, Pages 487-495

  Ragin, Ann B ^a   D'Souza, Gypsyamber ^b   Reynolds, Sandra ^b   Miller, Eric ^c   Sacktor, Ned ^d   Selnes, Ola A ^d   Martin, Eileen ^e   Visscher, Barbara R ^f   Becker, James T ^g  

^a NORTHWESTERN UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Hematologic; HIV; HIV dementia; Platelets; Volumetric MRI

Indexed keywords

HEMOGLOBIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BRAIN ATROPHY; BRAIN INJURY; CD4 LYMPHOCYTE COUNT; COGNITION; DISEASE SEVERITY; EDUCATIONAL STATUS; GRAY MATTER; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; RACE; SMOKING; THROMBOCYTE COUNT; VIRUS LOAD;

ADULT; AIDS DEMENTIA COMPLEX; BLOOD PLATELETS; BRAIN; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HIV; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PLATELET COUNT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 84856192540     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-011-0053-2     Document Type: Article

References (46)

1. Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, Neurobehavioral Research C (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 4:190-199
2. Angiolillo DJ, Ueno M, Goto S (2010) Basic principles of platelet biology and clinical implications. Circ J 74:597-607
3. Becker JT, Kingsley L, Mullen J, Cohen B, Martin E, Miller EN, Ragin A, Sacktor N, Selnes OA, Visscher BR, Multicenter ACS (2009) Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology 73:1292-1299
4. Becker JT, Maruca V, Kingsley LA, Sanders JM, Alger JR, Barker PB, Goodkin K, Martin E, Miller EN, Ragin A, Sacktor N, Selnes O (2011) Factors affecting brain structure in men with HIV disease in the post-HAART era. Neuroradiology (in press)
5. Boehlen F, Clemetson KJ (2001) Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 11:403-417 (Pubitemid 34044850)
6. Brass L (2010) Understanding and evaluating platelet function. Hematology 2010:387-396
7. Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chmiel JS, Visscher BR, Margolick JB, Dobs AS (2005) Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study. AIDS 19:1375-1383 (Pubitemid 41800673)
8. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95:3117-3121 (Pubitemid 28135864)
9. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46:391-398 (Pubitemid 29416277)
10. Depairon M, Chessex S, Sudre P, Rodondi N, Doser N, Chave JP, Riesen W, Nicod P, Darioli R, Telenti A, Mooser V, Swiss HIVCS (2001) Premature atherosclerosis in HIV-infected individuals-focus on protease inhibitor therapy. AIDS 15:329-334 (Pubitemid 32163818)
11. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505 (Pubitemid 36337492)
12. Ehrenreich H, Hasselblatt M, Knerlich F, von Ahsen N, Jacob S, Sperling S, Woldt H, Vehmeyer K, Nave KA, Siren AL (2005) A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proc Natl Acad Sci USA 102:862-867 (Pubitemid 40282756)
13. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I (1997) Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54:416-424 (Pubitemid 27172861)
14. Farinpour R, Miller EN, Satz P, Selnes OA, Cohen BA, Becker JT, Skolasky RL Jr, Visscher BR (2003) Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 25:654-670 (Pubitemid 36808151)
15. Gartner S (2000) HIV infection and dementia. Science 287:602-604 (Pubitemid 30070897)
16. Gawaz M, Neumann FJ, Dickfeld T, Koch W, Laugwitz KL, Adelsberger H, Langenbrink K, Page S, Neumeier D, Schomig A, Brand K (1998) Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. [see comment]. Circulation 98:1164-1171 (Pubitemid 28436165)
17. Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schomig A, Neumann F (2000) Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atheroscler 148:75-85
18. Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407-411 (Pubitemid 40446187)
19. Hsue PY, Lo JC, Franklin A, Bolger AF, Martin JN, Deeks SG, Waters DD (2004) Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109:1603-1608 (Pubitemid 38451715)
20. Janssen RS (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virustype 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41:778-785
21. Jurk K, Kehrel BE (2005) Platelets: physiology and biochemistry. Semin Thromb Hemost 31:381-392 (Pubitemid 41362342)
22. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr (1987) The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 126:310-318 (Pubitemid 17102758)
23. Klinger MH, Jelkmann W (2002) Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913-922 (Pubitemid 35155690)
24. Kornbluth RS (2000) The emerging role of CD40 ligand in HIV infection. J Leukoc Biol 68:373-382
25. Lin CI, Chen CN, Chen JH, Lee H (2006) Lysophospholipids increase IL-8 and MCP-1 expressions in human umbilical cord vein endothelial cells through an IL-1-dependent mechanism. J Cell Biochem 99:1216-1232 (Pubitemid 44673976)
26. Martin G, Roy J, Barat C, Ouellet M, Gilbert C, Tremblay MJ (2007) Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells. J Virol 81:5872-5881 (Pubitemid 46847024)
27. Mena ÁMM, Meijide H, Vázquez P, Castro Á, López S, Bello L, Serrano J, Baliñas J, Pedreira JD (2011) HIV increases mean platelet volume during asymptomatic HIV infection in treatmentnaive patients. J Acquir Immune Defic Syndr: JAIDS 57:e112-e113
28. Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, Hanai N, Irimura T (1993) Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 151:3267-3273 (Pubitemid 23282639)
29. Nebuloni M, Pellegrinelli A, Ferri A, Bonetto S, Boldorini R, Vago L, Grassi MP, Costanzi G (2001) Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 15:571-575 (Pubitemid 32281351)
30. Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC (2007) Biomarkers of HIV-1 CNS infection and injury. Neurology 69:1781-1788 (Pubitemid 350059307)
31. Prodan CI, Ross ED, Vincent AS, Dale GL (2008) Rate of progression in Alzheimer's disease correlates with coated-platelet levels-a longitudinal study. Transl Res 152:99-102
32. Prodan CI, Ross ED, Stoner JA, Cowan LD, Vincent AS, Dale GL (2011) Coated-platelet levels and progression from mild cognitive impairment to Alzheimer disease. Neurology 76:247-252
33. Ragin AB, Wu Y, Ochs R, Scheidegger R, Cohen BA, Edelman RR, Epstein LG, McArthur J (2010) Biomarkers of neurological status in HIV infection: a 3-year study. Proteomics Clin Appl 4:295-303
34. Ragin AB, Wu Y, Ochs R, Du H, Epstein LG, Conant K, McArthur JC (2011) Marked relationship between matrix metalloproteinase 7 and brain atrophy in HIV infection. J Neurovirol 17:153-158
35. Reitan R (1979) Manual for administration of neuropsychological test batteries for adults and children. Neuropsychology Laboratory, Tucson
36. Schonbeck U, Libby P (2001a) CD40 signaling and plaque instability. Circ Res 89:1092-1103 (Pubitemid 34627866)
37. Schonbeck U, Libby P (2001b) The CD40/CD154 receptor/ligand dyad. Cell Mol Life Sci 58:4-43 (Pubitemid 32143961)
38. Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, Epstein LG (2007) An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection. Arch Neurol 64:97-102 (Pubitemid 46072430)
39. Smith A (1982) The symbol digit modalities test manual. Western Psychological Services, Los Angeles
40. Stellos K, Panagiota V, Kogel A, Leyhe T, Gawaz M, Laske C (2010) Predictive value of platelet activation for the rate of cognitive decline in Alzheimer's disease patients. J Cereb Blood Flow Metab 30:1817-1820
41. Sui Z, Sniderhan LF, Schifitto G, Phipps RP, Gelbard HA, Dewhurst S, Maggirwar SB (2007) Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J Immunol 178:3226-3236 (Pubitemid 46333205)
42. Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, Holck P, Grove J, Sacktor N (2004) Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology 63:822-827 (Pubitemid 39297641)
43. Wachtman LM, Skolasky RL, Tarwater PM, Esposito D, Schifitto G, Marder K, McDermott MP, Cohen BA, Nath A, Sacktor N, Epstein LG, Mankowski JL, McArthur JC (2007) Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus-associated dementia. Arch Neurol 64:1264-1272 (Pubitemid 47403080)
44. Wang J, Zhang W, Nardi MA, Li Z (2011) HIV-1 Tat-induced platelet activation and release of CD154 contribute to HIV-1-associated autoimmune thrombocytopenia. J Thromb Haemost 9:562-573
45. Weyrich AS, Zimmerman GA (2004) Platelets: signaling cells in the immune continuum. Trends Immunol 25:489-495 (Pubitemid 39490256)
46. Weyrich AS, Elstad MR, McEver RP, McIntyre TM, Moore KL, Morrissey JH, Prescott SM, Zimmerman GA (1996) Activated platelets signal chemokine synthesis by human monocytes. J Clin Investig 97:1525-1534 (Pubitemid 26097043)